Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipient

Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipient

  • CN 102,764,242 A
  • Filed: 02/19/2003
  • Published: 11/07/2012
  • Est. Priority Date: 02/20/2002
  • Status: Active Application
First Claim
Patent Images

1. be used for the tablet of sl. sol. PDE 4 inhibitor of oral administration or the dosage form of pill;

  • It comprises sl. sol. PDE 4 inhibitor and polyvinylpyrrolidone;

    With one or more other suitable drug excipient;

    Wherein said PDE 4 inhibitor are that N-(3,5-dichloropyridine-4-yl)-3-cyclo propyl methoxy-4-difluoro-methoxy Benzoylamide (roflumilast) and wherein said dosage form are the solid oral dosage forms (discharging solid oral dosage form immediately) of release of active ingredients immediately.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×